Dashboard
Manage Tickers

IVAInventiva S.A.

Nasdaq inventivapharma.com


$ 2.73 $ -0.01 (-0.46 %)    

Monday, 15-Jul-2024 09:29:44 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 496.90 $ 1.33 (0.27 %)
DIA $ 402.52 $ 2.04 (0.51 %)
SPY $ 561.53 $ 1.54 (0.28 %)
TLT $ 92.88 $ -1.08 (-1.15 %)
GLD $ 223.86 $ 0.72 (0.32 %)
$ 2.6678
$ 2.73
$ 2.62 x 400
$ 0.00 x 0
$ 2.73 - $ 2.73
$ 2.47 - $ 4.75
6,158
na
139.03M
$ 1.16
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

gold-falls-over-1-hillevax-shares-plunge
Gold Falls Over 1%; HilleVax Shares Plunge
07/08/2024 18:31:08

why-arhaus-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Arhaus Shares Are Trading Lower By Aro...
07/08/2024 17:16:55

dow-turns-lower-myomo-shares-jump
Dow Turns Lower; Myomo Shares Jump
07/08/2024 16:07:35

why-paramount-global-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket
Why Paramount Global Shares Are Trading Hi...
07/08/2024 09:40:41

inventiva-estimates-that-its-cash-cash-equivalents-and-deposits-will-allow-the-co-to-fund-its-operations-as-planned-through-h2-of-july-2024-estimates-that-as-of-may-31-2024-cash-and-cash-equivalents-were-96-million
Inventiva Estimates That Its Cash, Cash Eq...
07/05/2024 20:02:27

Financial updateConsidering the Company's cost structure and forecasted expenditures, and without taking into account addit...

provides-an-update-on-its-nativ3-clinical-program-evaluating-lanifibranor-in-patients-with-mashnash
Provides An Update On Its NATiV3 Clinical ...
07/05/2024 20:02:25

Recruitment in NATiV3 clinical trial continues in both cohorts with over 80% of the targeted number of patients enrolled in the...

inventiva-cash-and-cash-equivalents-amounted-to-110-million-as-of-march-31-2024
Inventiva Cash And Cash Equivalents Amount...
05/21/2024 20:03:08

Key Financial ResultsCash, cash equivalents and depositsAs of March 31, 2024, the Company's cash and cash equivalents amoun...

inventiva-receives-recommendation-from-the-4th-scheduled-data-monitoring-committee-meeting-of-the-nativ3-phase-iii-clinical-trial-with-lanifibranor-in-patients-with-mashnash
Inventiva Receives Recommendation From The...
05/16/2024 20:02:06

The Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on...

why-is-inventivas-stock-trading-higher-on-monday
Why Is Inventiva's Stock Trading Higher on...
05/13/2024 18:08:33

Inventiva's Lanifibranor improves cardiometabolic health in MASH/NASH patients. It lowers fasting glucose, reduces cardiova...

inventiva-announces-the-publication-in-nature-communications-of-additional-results-from-native-phase-iib-clinical-trial-demonstrating-improvement-of-markers-of-cardiometabolic-health-in-patients-with-mashnash-treated-with-lanifibranor
Inventiva Announces the Publication in Nat...
05/13/2024 07:12:28

Inventiva (NASDAQ:IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies ...

canaccord-genuity-maintains-buy-on-inventiva-raises-price-target-to-20
Canaccord Genuity Maintains Buy on Inventi...
04/08/2024 11:44:13

Canaccord Genuity analyst Edward Nash maintains Inventiva (NASDAQ:IVA) with a Buy and raises the price target from $12 to $20.

hc-wainwright--co-reiterates-buy-on-inventiva-maintains-22-price-target
HC Wainwright & Co. Reiterates Buy on Inve...
04/01/2024 10:22:18

HC Wainwright & Co. analyst Ed Arce reiterates Inventiva (NASDAQ:IVA) with a Buy and maintains $22 price target.

inventiva-fy23-243-vs-131-yoy-revenues-for-2023-amounted-to-175-million-up-by-434-compared-to-122-million-in-2022
Inventiva FY23 €(2.43) Vs €(1.31) YoY; Rev...
03/27/2024 20:03:57

Key financial results for the full year of 2023As of December 31, 2023, the Company's cash and cash equivalents amounted to...

hc-wainwright--co-reiterates-buy-on-inventiva-maintains-22-price-target
HC Wainwright & Co. Reiterates Buy on Inve...
03/20/2024 12:17:50

HC Wainwright & Co. analyst Ed Arce reiterates Inventiva (NASDAQ:IVA) with a Buy and maintains $22 price target.

inventiva-snnounces-results-from-the-phase-ii-legend-proof-of-concept-study-combining-lanifibranor-with-empagliflozin-in-patients-with-mashnash-and-t2d
Inventiva Snnounces Results From The Phase...
03/18/2024 20:01:11

LEGEND achieved its primary efficacy endpoint by significantly lowering HbA1c level in both the lanifibranor arm and in the lan...

inventiva-to-present-the-results-of-legend-phase-iia-combination-trial-with-lanifibranor-and-empagliflozin-in-patients-with-mashnash-and-t2d-in-an-investor-conference-on-tuesday-march-19
Inventiva To Present The Results Of LEGEND...
03/13/2024 20:01:56

Inventiva (NASDAQ:IVA) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral s...

hc-wainwright--co-maintains-buy-on-inventiva-announces-22-price-target
HC Wainwright & Co. Maintains Buy on Inven...
03/08/2024 17:48:49

HC Wainwright & Co. analyst Ed Arce maintains Inventiva (NASDAQ:IVA) with a Buy and announces $22 price target.

inventiva-resumes-screening-in-nativ3-phase-iii-clinical-trial-evaluating-lanifibranor-in-nash
Inventiva Resumes Screening In NATiV3, Pha...
03/07/2024 21:01:44

Inventiva has lifted the voluntary pause on screening and randomization in the NATiV3 clinical trial following the approval fro...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
02/19/2024 17:30:50

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
02/19/2024 13:05:48

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)
07/30/2024 Rivian Automotive, Inc. (RIVN)
07/30/2024 Hertz Global Holdings, Inc. (HTZ)
08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)